Gofar Stock(SH:600538)2020-10-29 16:00Financial Performance - Net profit attributable to shareholders was a loss of CNY 5,301,691.17, an improvement from a loss of CNY 6,132,891.07 in the same period last year[5] - Operating revenue for the first nine months was CNY 181,341,788.70, down 0.92% year-on-year[5] - The weighted average return on net assets improved to -0.82% from -0.97% year-on-year[5] - The company reported a basic and diluted earnings per share of -0.01 CNY, consistent with the previous year[5] - Other income increased by 86.15% to RMB 1,061,342.08 compared to RMB 570,161.19 in the same period last year[12] - Investment income decreased significantly by 147.46% to -RMB 1,451,300.29 from RMB 3,057,693.27[12] Cash Flow - The net cash flow from operating activities was CNY 3,346,151.16, a significant recovery from a negative cash flow of CNY 8,152,078.15 in the previous year[5] - Net cash flow from operating activities improved to RMB 3,346,151.16 from -RMB 8,152,078.15, a change of RMB 11,498,229.31[17] - Net cash flow from investing activities decreased by 117.09% to -RMB 31,134,322.39 from RMB 182,190,663.61[17] Shareholder Information - The number of shareholders reached 22,344, indicating a stable shareholder base[9] - The largest shareholder, Zhu Rongjuan, holds 28.46% of the shares, with 88,190,000 shares pledged[9] - Chairman and President Pan Libin reduced his shareholding by 4,590,150 shares, accounting for 0.9884% of the total shares[23] Asset Management - Total assets decreased by 1.62% to CNY 737,922,494.53 compared to the end of the previous year[5] - The company reported a significant increase in prepaid expenses due to a major asset restructuring, with the ending balance rising compared to the beginning balance[11] - Long-term equity investments increased as the company made a third capital contribution to Nanjing Huada Gongying No.1 Venture Capital Enterprise, as per the partnership agreement[11] - Long-term equity investments rose by 41.04% to RMB 98,112,015.58 from RMB 69,563,315.87[12] Operational Efficiency - The company is focusing on improving operational efficiency and exploring new market opportunities to enhance future performance[5] - Research and development expenses decreased by 55.84% to RMB 22,844.21 from RMB 51,728.31 year-on-year[12] Government Support - Non-operating income included government subsidies amounting to CNY 767,339.59 for the period[5] - The company received government subsidies totaling RMB 1,015,993.16 from January 1 to July 20, 2020[20] Other Information - The balance of contract liabilities and advance receipts changed due to the implementation of new revenue standards starting January 1, 2020, which led to a reclassification of advance payments[11] - The balance of payable employee compensation decreased as the company paid out year-end bonuses that were accrued from the previous year[11] - The balance of taxes payable decreased due to payments made for taxes accrued at the end of the previous year[11] - There are no overdue commitments or significant changes in cumulative net profit expected compared to the same period last year[24] - The report is dated October 29, 2020, for Beihai Guofa Marine Biological Industry Co., Ltd.[24] - The company is in the process of a major asset restructuring to acquire 99.9779% of Guangzhou Gaosheng Biotechnology Co., Ltd.[16] - The company donated a total of 50,000 bottles of ethanol disinfectant to various hospitals and organizations to combat COVID-19[22]